NEW YORK, November 1, 2016 /PRNewswire/ --
On Monday, October 31, 2016, the NASDAQ
On Monday, shares in Newport Beach, California headquartered Acacia Research Corp. ended the session 3.31% lower at $5.85 with a total volume of 469,717 shares traded. Acacia Research's stock is trading 20.05% above its 200-day moving average. Moreover, shares of the Company, which through its subsidiaries, invests in, develops, licenses, and enforces patented technologies in the US, have a Relative Strength Index (RSI) of 41.43. Visit us today and download your complete report on ACTG for free at:
Cincinnati, Ohio headquartered Convergys Corp.'s stock finished Monday's session 0.55% higher at $29.20 with a total volume of 500,330 shares traded. Over the past three months and the previous one year, Convergys' shares have gained 10.03% and 15.22%, respectively. Shares of the Company, which provides customer management services to communications and media, technology, financial services, retail, and healthcare industries in North America and internationally, are trading at a PE ratio of 17.07. The Company's shares are trading above its 200-day moving average by 7.77%. Convergys' stock has an RSI of 43.24. The complimentary research report on CVG can be accessed at:
Healthcare Services Group
On Monday, shares in Bensalem, Pennsylvania-based Healthcare Services Group Inc. recorded a trading volume of 463,101 shares. The stock ended the day 0.03% lower at $36.97. Shares of the Company, which provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments to nursing homes, retirement complexes, rehabilitation centers, and hospitals in the US, are trading at a PE ratio of 40.58. Healthcare Services' stock has advanced 1.19% in the past one year. The Company is trading below its 50-day and 200-day moving averages by 4.28% and 1.31%, respectively. Furthermore, shares of Healthcare Services Group have an RSI of 37.48. Register for free on Stock-Callers.com and download the PDF research report on HCSG at:
Atlanta, Georgia headquartered Rollins Inc.'s stock edged 0.49% higher, to close the day at $30.82. The stock recorded a trading volume of 593,397 shares, which was above its three months average volume of 433,190 shares. Rollins' shares have gained 5.26% in the last one month, 10.23% in the previous three months and 17.00% in the past one year. Shares of the Company, which through its subsidiaries, provides pest and termite control services to residential and commercial customers, are trading 7.34% and 10.98% above its 50-day and 200-day moving averages, respectively. Additionally, the stock traded at a PE ratio of 43.04 and has an RSI of 75.71. Get free access to your research report on ROL at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!